Fukang Group

Shandong Fukang Pharmaceutical, commonly known as Fukang Group, is a large-scale Chinese pharmaceutical enterprise specializing in the research, development, and high-volume manufacturing of Active Pharmaceutical Ingredients (APIs) and finished dosage forms. The company is a global leader in the production of beta-lactam antibiotics, particularly within the penicillin and cephalosporin classes, and operates one of the largest production bases for these products in China. With extensive GMP-certified facilities, Fukang serves as a critical supplier for both domestic healthcare needs and international pharmaceutical markets across Europe, the Americas, and Asia. Their product portfolio also extends into cardiovascular, gastrointestinal, and metabolic therapeutic areas, providing a wide range of essential generic medications. The group maintains a vertically integrated structure, managing the entire value chain from chemical synthesis to large-scale commercial distribution.